What are the recommended psychiatric management strategies for patients undergoing a transition in dialysis modality?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psychiatric Management Strategies for Patients Transitioning Between Dialysis Modalities

Patients undergoing dialysis modality transitions should receive routine screening for depression and anxiety, with access to a multidisciplinary team including mental health professionals to provide psychological support through this challenging period. 1

Assessment and Screening

  • Routine screening for depression and anxiety should be implemented for all patients transitioning between dialysis modalities, as this is a period of psychological vulnerability 1
  • The Beck Depression Inventory (BDI) is a well-validated screening instrument for depression in dialysis patients, with scores ≥14 indicating need for psychiatric referral 2
  • The Cognitive Depression Index, a subset of the BDI, helps control for somatic symptoms that may artificially inflate depression rates in dialysis patients 1
  • Other validated screening tools include the Patient Health Questionnaire (PHQ) and Center for Epidemiologic Studies Depression Scale (CESD) 2
  • The Structured Clinical Interview for DSM disorders (SCID) remains the gold standard for diagnosis of depression in this population 2

Psychological Interventions

  • Cognitive Behavioral Therapy (CBT) is recommended as a first-line intervention for depression in dialysis patients, with moderate-certainty evidence showing it reduces depressive symptoms and improves quality of life 3
  • CBT helps patients with dialysis through cognitive changes related to illness perception, experiencing pleasant emotions, and feeling seen and understood 4
  • Counseling may provide modest benefits in reducing depressive symptoms in dialysis patients 3
  • Exercise programs should be incorporated when physically possible, as they probably improve depression symptoms with moderate certainty 3
  • Relaxation techniques show moderate-certainty evidence for reducing depressive symptoms and should be considered as part of treatment 3
  • Peer support should be incorporated into educational tools to help patients cope with the transition between dialysis modalities 1

Pharmacological Management

  • If patients exhibit depressive or anxiety symptoms that don't respond to non-pharmacological treatments, psychotropic medication should be considered 1
  • Selective Serotonin Reuptake Inhibitors (SSRIs) or atypical antidepressants such as nefazodone or bupropion may be preferred for dialysis patients with depression, as they may have fewer potential negative cardiovascular effects 1
  • However, caution is warranted with SSRIs due to their adverse effect profile in dialysis patients, with small trials showing increased gastrointestinal side effects and inconsistent benefits over placebo 1
  • When prescribing psychotropic medications, start with lower doses and carefully titrate up while monitoring for adverse effects 1
  • Consider potential drug interactions, altered pharmacokinetics, and QT prolongation risks in the setting of kidney failure 1

Multidisciplinary Approach

  • Patients with failing kidney function should have access to multidisciplinary teams to allow a seamless transition of care between dialysis modalities 1
  • The team should include nephrologists, social workers, dieticians, healthcare navigators, and emotional support staff 1
  • When the eGFR is ≤20 ml/min per 1.73 m², or if rapid decline occurs, communication between transplantation and dialysis teams should begin 1
  • Adequate dialysis and anemia control are important contributors to overall well-being and quality of life and should be optimized 1
  • Masters-prepared social workers with clinical specialization should perform psychological and social assessments of patients when they begin dialysis and reassess stable patients every six months 1

Special Considerations

  • Depression is the most common psychiatric illness in end-stage renal disease patients, with prevalence ranging from 22.8% (interview-based diagnosis) to 39.3% (self- or clinician-administered rating scales) 2
  • Depression is a significant predictor of mortality in dialysis patients, making effective management critical 2
  • Dialysis patients exhibit higher rates of psychiatric morbidity compared to transplant patients, with 43% falling into the probable psychiatric case range 5
  • Psychological distress in dialysis patients is characterized by loss of emotional control and higher levels of depression 5
  • The symptom burden in dialysis patients may be exacerbated by medications, highlighting the importance of regular medication review 6
  • Non-pharmacological alternatives like music therapy have shown benefits for anxiety and pain perception in dialysis patients 7

Implementation Strategies

  • Develop educational tools (videos, webinars, brochures) to help patients prepare for and accept the transition between dialysis modalities 1
  • Consider a multidisciplinary patient integrated care clinic (MDC) specifically for patients transitioning between dialysis modalities 1
  • Address financial concerns and insurance issues related to changing dialysis modalities, as these can contribute to psychological stress 1
  • Implement trauma-informed care approaches, acknowledging patients' past and present exposures to trauma, especially for those with unstable housing 1
  • Bundle lab and clinic visits when possible to improve consistency of contact and promote trusting relationships with providers 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Depression in dialysis patients.

Nephrology (Carlton, Vic.), 2016

Research

How Are People Undergoing Dialysis Expected to Benefit From Cognitive Behavioural Therapy? A Realist Analysis.

Health expectations : an international journal of public participation in health care and health policy, 2025

Guideline

Pregabalin Use in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pregabalin Use in Hospitalized Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.